Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q4 EPS of ($3.42), $3.23 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.48 million.

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.